These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3695637)

  • 41. A survey of generic drug legislation and geriatric pharmacotherapy: opinions of those who generate the literature.
    Morgan JP; Schwartz LL; Sherman FT
    J Am Geriatr Soc; 1983 Sep; 31(9):535-9. PubMed ID: 6886279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
    Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacists' experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin.
    Olsson E; Kälvemark Sporrong S
    Int J Pharm Pract; 2012 Dec; 20(6):377-83. PubMed ID: 23134096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shooting from the 'Scrip: Scope of Practice Laws and Access to Immunizations in the Pharmacy Setting.
    Stoecker C
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34063185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug product selection: the Florida experience.
    Vuturo GJ; Krischer JP; McCormick WC
    Am J Public Health; 1980 May; 70(5):479-84. PubMed ID: 7377418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic substitution in the health maintenance organization outpatient environment.
    Doering PL; Russell WL; McCormick WC; Klapp DL
    Drug Intell Clin Pharm; 1988 Feb; 22(2):125-30. PubMed ID: 3349928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Legal requirements for pharmacists to destroy unused medications in skilled nursing facilities. - A 50 state review and insights based on the Covid-19 pandemic.
    Manjounes A; Lavino J
    Res Social Adm Pharm; 2022 May; 18(5):2894-2897. PubMed ID: 34362687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 52. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
    Maly J; Dosedel M; Kubena A; Vlcek J
    Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [How do pharmacists evaluate the newly introduced system of substituting prescriptions?].
    Rubak SL; Andersen ML; Mainz J; Olesgaard P; Laursen K; Schaumann M; Lauritzen T
    Ugeskr Laeger; 2000 Nov; 162(45):6074-7. PubMed ID: 11107945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Ping CC; Bahari MB; Hassali MA
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mislabeling and patient liability issues for pharmacists.
    Fink JL
    Contemp Pharm Pract; 1981; 4(4):207-10. PubMed ID: 10256892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liability of pharmacists for substitution of a generic drug for its brand-name counterpart.
    Hirsh HL
    Med Law; 1987; 6(4):293-302. PubMed ID: 3613889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.